Universal Starch Chem Allied Ltd
Universal Starch Chem Allied Ltd: Q2 FY27 Un-Audited Financial Results Approved
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 07 Nov 2026, 02:39 PM IST · BSE ID: c9e1b9f1-f28f-4dff-bbf4-9ddbd13f305d
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has officially approved its financial performance report for the last quarter and half-year.
🤖 AI Summary
- Universal Starch Chem Allied Ltd's Board approved Standalone Un-Audited Financial Results for Q2 FY27.
- The financial results cover the quarter and half-year period ended September 30, 2026.
- A Limited Review Report from the Statutory Auditor was issued alongside the financial results.
- The Board Meeting commenced at 11:00 am and concluded at 02:30 pm on November 7, 2026.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this announcement.
👤
Who Is Affected
All shareholders are affected as the company has completed a standard financial reporting process, awaiting the public release of the actual financial figures.
🔍
Management Signal
The board's approval of the un-audited financial results indicates adherence to regulatory timelines for financial reporting.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Public release of Q2 FY27 Standalone Un-Audited Financial Results for specific figures.
Review of the full Limited Review Report from the Statutory Auditor.
Next Board Meeting for Q3 FY27 results approval and other corporate actions.
LOW RISK
This is a routine announcement of board meeting outcome, no new risks introduced.
💡 Investor Takeaway
Universal Starch Chem Allied Ltd's Board of Directors approved the Standalone Un-Audited Financial Results for the quarter and half-year ended September 30, 2026 (Q2 FY27), including the Statutory Auditor's Limited Review Report. This confirms the timely completion of a mandatory disclosure process.
📅 Company Track Record
Universal Starch Chem Allied Ltd previously informed BSE on October 31, 2026, about the Board Meeting scheduled for November 7, 2026, to approve the Q2 and half-year FY27 financial results. This current filing confirms the completion of that planned meeting and the approval of the results.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What financial period do the approved results cover?
The approved results cover the quarter and half-year period ended September 30, 2026, which corresponds to Q2 FY27.
When did Universal Starch Chem Allied Ltd's Board Meeting take place?
The Board Meeting commenced at 11:00 am and concluded at 02:30 pm on November 7, 2026.
What type of financial results were approved by the Board?
The Board approved Standalone Un-Audited Financial Results, accompanied by a Limited Review Report issued by the Statutory Auditor.
Questions based on this BSE filing only. For information purposes.